Pharmacy Compliance Update 2016 & What Would Cause a DEA Administrative Action or Civil Fine ∙ 3 Contact Hours
Date: Wednesday, March 9, 2016
Where: LaGuardia Marriott Hotel
Exit 94th Street off Grand
102-05 Ditmars Blvd.
East Elmhurst, NY 11369
Registration: 6:30 PM
Dinner: 6:30 PM
CE Program: 7:00 - 10:00 PM
Presenters, James Schiffer, RPh, JD & Carlos Aquino,Compliance Consultant, PharmaDiversion
Program #: 0170-0000-16-018-L03-P
3 Contact Hours
Knowledge Based Activity
At the completion of this activity, the participant will be able to:
• identify the key issues which pharmacy benefit managers audit during routine pharmacy investigations and audits;
• describe the actions taken by various government agencies when overpayments are identified in audits of pharmacies;
• identify the process needed for confirmation of the eligibility of the prescribers who submit prescriptions under state or federal prescription programs;
• define the role of DEA Diversion personnel who enforce pharmaceutical federal laws under the Controlled Substances Act and related DEA regulations;
• identify examples of civil actions and fines resulting from the DEA registrant’s failure to maintain complete and accurate records and an accurate controlled substance inventory;
• identify each element of a DEA inspection which includes required DEA records security of controlled substances and the requisite due diligence for dispensing controlled substances;
• describe and define the results of a revocation of a pharmacy DEA registration by citing the most recent results of DEA administrative hearings.
The Pharmacists Society of the State of New York is accredited by the Accreditation Council of Pharmacy Education as a provider of continuing pharmacy education.